Related Experiment Video
Updated: Feb 12, 2026

In Situ Visualization of Axon Growth and Growth Cone Dynamics in Acute Ex Vivo Embryonic Brain Slice Cultures
Published on: October 14, 2021
Design of the long-term observational cohort study with recombinant human growth hormone in Korean children: LG
Sochung Chung1, Jae-Ho Yoo2, Jin Ho Choi3
1Department of Pediatrics, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
Insights
This registry study tracks Korean children using recombinant human growth hormone (rhGH) to assess its safety and effectiveness. It aims to provide crucial long-term data on growth outcomes and adverse events in this population.
Area of Science:
- Pediatric Endocrinology
- Pharmacovigilance
- Growth Hormone Therapy
Background:
- Limited long-term follow-up data exist for recombinant human growth hormone (rhGH) use in Korean pediatric patients.
- Real-world data are essential for understanding the safety and effectiveness of rhGH treatments.
- A comprehensive registry study is needed to address this knowledge gap.
Purpose of the Study:
- To establish a registry (LG Growth Study) for assessing the safety and effectiveness of four rhGH products in Korean children.
- To collect prospective data on treatment and adverse events, with a focus on malignancies and growth outcomes.
- To provide long-term follow-up data in a real-life clinical setting.
Main Methods:
- Prospective enrollment of 4,000 children for follow-up at 6-month intervals.
- Data collection until 2 years post-epiphyseal closure, focusing on malignancies and growth.
- Inclusion of diverse pediatric conditions, including growth hormone deficiency and idiopathic short stature.
Main Results:
- As of March 2017, 2,024 patients were included, with growth hormone deficiency being the most common indication (64.1%).
- Baseline characteristics included a median age of 8 years, with 52% males and predominantly Tanner stage I.
- Median height standard deviation score was -2.26, and median bone age delay was -1.46 years.
Conclusions:
- The LG Growth Study will offer valuable insights into the safety profile, including malignancy risk, of rhGH in Korean pediatric patients.
- Long-term effectiveness data will be generated, aiding in understanding standard rhGH treatment protocols.
- Comparative analyses between different disease entities will inform clinical decision-making.
Purpose:
Regarding recombinant human growth hormone (rhGH) use in the pediatric population, no long-term follow-up data are available for Korean patients. To fill in the gap of knowledge, a registry study (LG Growth Study) was initiated to assess the safety and effectiveness of four types of rhGH products in real-life settings.
Methods:
A total of 4,000 children will be registered and prospectively followed up at 6-month intervals until 2 years after epiphyseal closure to collect data on treatment and adverse events, with primary interest in malignancies and growth outcomes.
Results:
As of 22 March 2017, approximately 50% (2,024) of the target number of patients have been included in the analysis set: growth hormone deficiency, 1,297 (64.1%); idiopathic short stature, 315 (15.6%); small for gestational age, 206 (10.2%); Turner syndrome, 197 (9.7%); and chronic renal failure, 9 (0.4%). At baseline, median age (years) was 8 (interquartile range [IQR], 5-11); 52% (1,048) were boys; and the majority were at Tanner stage I (83% based on breast/external genitalia, 97% on pubic hair). Median height standard deviation score was -2.26 (IQR, -2.69 to -2.0), and median bone age delay (years) was -1.46 (IQR, -2.26 to -0.78).
Conclusions:
This registry study will provide the opportunity to assess the risk of malignancies as well as the general safety data in Korean pediatric patients receiving rhGH. In addition, the long-term effectiveness of rhGH and comparative data between different disease entities will provide practical insight on the standard rhGH treatment.
Related Concept Videos
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
Population Growth
Meristems and Plant Growth
Primary and Secondary Growth in Roots and Shoots
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...

